Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Fuzheng 3
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acquired Immune Deficiency Syndrome Virus
1 trial -
G-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Intrauterine Adhesion
1 trial -
G-CSF (Granulocyte colony-stimulating factor)
The First People's Hospital of Lianyungang
Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
1 trial -
GD007 Low-dose drug group
The First People's Hospital of Lianyungang
Moderate-Severe Intrauterine Adhesions
1 trial -
GDMT
The First People's Hospital of Lianyungang
Heart Failure With Preserved Ejection Fraction
1 trial -
GE Logiq E10 clinical ultrasound scanner
United Therapeutics Europe Ltd
Breast Tumor
1 trial -
GLP-1 Receptor Agonists
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Short Bowel Syndrome (SBS)
1 trial -
Gabapentin
United Therapeutics Europe Ltd
Sciatica
1 trial -
Gabapentin
Hospital Authority, Hong Kong
Spinal Fusion
1 trial -
Galantamine
BRIGHT MINDS BIOSCIENCES INC.
Addiction
1 trial -
Gastrodin Injection
The First People's Hospital of Lianyungang
Sensorineural Hearing Loss
1 trial -
Gastrografin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
CRE-induced SBO
1 trial -
Gefitinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Gemcitabine
HALOZYME THERAPEUTICS, INC.
Pancreatic Cancer
1 trial -
Gemcitabine, cisplatin
The First People's Hospital of Lianyungang
Bladder Cancer
1 trial -
Gene detection of therapeutic drugs for chronic cardiovascular and cerebrovascular diseases
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension,Essential
1 trial -
General Anesthesia
United Therapeutics Europe Ltd
Facial Injuries
1 trial -
Generic cetrorelix acetate
NORTHWEST BIOTHERAPEUTICS INC
Infertility
1 trial -
Genetic testing for 4 MODY genes (GCK, HNF1A, HNF4A, HNF1B)
United Therapeutics Europe Ltd
Maturity-onset Diabetes of the Young
1 trial -
Genotype detected through GenSeizer high-throughput gene capture technology
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non - Tuberculosis Mycobacteria Lung Disease
1 trial -
Ginkgo Biloba Extract
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
Glimepiride
Takeda
Type 2 Diabetes
1 trial -
Glutamine
United Therapeutics Europe Ltd
Hemorrhagic Shock
1 trial -
Gluten
Takeda
Celiac Disease
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources